ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2017. The put-call ratio across all filers is 3.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $212,000 | -67.1% | 10,000 | -56.5% | 0.01% | -70.8% |
| Q1 2021 | $645,000 | +7.9% | 23,000 | 0.0% | 0.02% | -11.1% |
| Q4 2020 | $598,000 | -83.7% | 23,000 | -76.6% | 0.03% | -85.8% |
| Q3 2020 | $3,661,000 | -27.6% | 98,500 | 0.0% | 0.19% | -32.6% |
| Q2 2020 | $5,054,000 | +71.8% | 98,500 | +5.6% | 0.28% | +34.3% |
| Q1 2020 | $2,942,000 | -46.9% | 93,300 | -42.0% | 0.21% | -32.7% |
| Q4 2019 | $5,538,000 | +66.2% | 160,900 | +77.0% | 0.31% | +55.2% |
| Q3 2019 | $3,332,000 | -6.0% | 90,900 | +19.3% | 0.20% | -7.4% |
| Q2 2019 | $3,545,000 | +48.4% | 76,200 | +28.1% | 0.22% | +46.6% |
| Q1 2019 | $2,389,000 | +477.1% | 59,500 | +561.1% | 0.15% | +428.6% |
| Q4 2018 | $414,000 | +3.8% | 9,000 | 0.0% | 0.03% | +21.7% |
| Q3 2018 | $399,000 | +13.0% | 9,000 | 0.0% | 0.02% | +9.5% |
| Q2 2018 | $353,000 | -92.3% | 9,000 | -92.0% | 0.02% | -92.9% |
| Q1 2018 | $4,609,000 | -7.0% | 112,600 | +49.5% | 0.29% | -5.8% |
| Q4 2017 | $4,958,000 | +56.3% | 75,300 | +19.0% | 0.31% | +26.8% |
| Q3 2017 | $3,173,000 | +8.3% | 63,300 | 0.0% | 0.25% | +3.4% |
| Q2 2017 | $2,930,000 | +102.3% | 63,300 | +54.4% | 0.24% | +98.3% |
| Q1 2017 | $1,448,000 | +624.0% | 41,000 | +355.6% | 0.12% | +34.8% |
| Q4 2015 | $200,000 | – | 9,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,629,835 | $116,685,000 | 25.08% |
| Aviva Holdings Ltd. | 1,200,100 | $53,248,000 | 14.21% |
| Boxer Capital, LLC | 1,375,000 | $61,009,000 | 6.77% |
| BB BIOTECH AG | 3,282,964 | $145,665,000 | 3.86% |
| Rhenman & Partners Asset Management AB | 353,961 | $15,705,000 | 1.57% |
| PFM Health Sciences, LP | 1,970,134 | $87,415,000 | 1.28% |
| Bellevue Group AG | 391,852 | $17,386,000 | 1.10% |
| Pentwater Capital Management LP | 2,351,500 | $104,336,000 | 0.88% |
| Partner Investment Management, L.P. | 25,440 | $1,129,000 | 0.86% |
| SABBY MANAGEMENT, LLC | 100,369 | $4,453,000 | 0.57% |